Pfizer Says Its New COVID-19 Pill Reduces Risk of Hospitalization And Death

The pill could "eliminate up to nine out of ten hospitalizations." 💊

Senior Global Editor
Pfizer Says Its New COVID-19 Pill Reduces Risk of Hospitalization And Death

Pfizer says its antiviral COVID-19 pill reduces the risk of hospitalization and death by 89%.

The company announced the positive results of a major trial involving the pill on Friday, adding that it's now going straight to the U.S. Food and Drug Administration for approval.

"Today's news is a real game-changer," Pfizer chairman and CEO Albert Bourla said in a statement. He added that the pills could save lives and "eliminate up to nine out of ten hospitalizations."

The drug, called Paxlovid, is meant to be taken "at the first sign of infection," according to Pfizer. The same kind of drug has been used to treat HIV.

The news follows the U.K.'s approval of pharmaceutical company Merck's COVID-19 pill on Thursday.

Both pills are meant to be taken after you've already been infected by the coronavirus, and work to slow down the virus' ability to spread.

The pills are not meant to replace vaccines.

Instead, they're designed to be a first response after infection — especially if you're at higher risk of getting really sick.

The U.K. is the only country to have approved a COVID-19 pill so far, but U.S. experts are expected to begin reviewing them sometime this month.

Health Canada has a robust website with all the latest information on COVID-19 vaccines and can answer any questions you may have.

Health Canada has recently approved the use of Pfizer's COVID-19 antiviral treatment PAXLOVID, and Justin Trudeau says 30,000 of the 1 million treatment courses Canada has secured have already arrived in the country.

The prime minister also revealed that Canada would be receiving at least 120,000 more of the PAXLOVID treatments by March, meaning the country still has another 850,000 to come.

Keep Reading Show less

Health Canada Just Approved At-Home Antiviral Pills For Eligible People With COVID-19

It's Canada's first COVID-19 therapy that can be taken at home.👇

Health Canada has approved the use of Pfizer's COVID-19 antiviral treatment PAXLOVID, which it says is the "first COVID-19 therapy that can be taken at home."

In a statement on Monday, January 17, the federal agency announced that the prescription-only medication had been authorized to treat adults with mild to moderate COVID-19, who are at risk of progressing to hospitalization or death.

Keep Reading Show less

The top doctor in B.C. compared the Pfizer and Moderna vaccines and said that one has a "stronger" effect.

If you're planning to get your booster dose soon, you might be wondering if there's a difference between the COVID-19 vaccines, especially with the emergence of the Omicron variant.

Keep Reading Show less

Many people are just signing up for their third vaccine dose, but now there comes news that we might need a booster on top of our booster.

Moderna CEO Stephane Bancel says he thinks that a fourth dose of COVID-19 vaccine will be needed to keep people protected from the virus, and it might be needed sooner than you think.

Keep Reading Show less